Follow
Samuel Volchenboum
Samuel Volchenboum
Assistant Professor of Pediatrics, University of Chicago
Verified email at peds.bsd.uchicago.edu
Title
Cited by
Cited by
Year
Scalable and accurate deep learning with electronic health records
A Rajkomar, E Oren, K Chen, AM Dai, N Hajaj, M Hardt, PJ Liu, X Liu, ...
NPJ digital medicine 1 (1), 1-10, 2018
20562018
1,135 genomes reveal the global pattern of polymorphism in Arabidopsis thaliana
C Alonso-Blanco, J Andrade, C Becker, F Bemm, J Bergelson, ...
Cell 166 (2), 481-491, 2016
11342016
Advances in risk classification and treatment strategies for neuroblastoma
NR Pinto, MA Applebaum, SL Volchenboum, KK Matthay, WB London, ...
Journal of clinical oncology 33 (27), 3008, 2015
8032015
Epigenomic diversity in a global collection of Arabidopsis thaliana accessions
T Kawakatsu, SSC Huang, F Jupe, E Sasaki, RJ Schmitz, MA Urich, ...
Cell 166 (2), 492-505, 2016
6252016
Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube
MA Eckert, S Pan, KM Hernandez, RM Loth, J Andrade, SL Volchenboum, ...
Cancer discovery 6 (12), 1342-1351, 2016
1972016
Pharmacogenomics‐based point‐of‐care clinical decision support significantly alters drug prescribing
PH O'Donnell, N Wadhwa, K Danahey, BA Borden, SM Lee, JP Hall, ...
Clinical Pharmacology & Therapeutics 102 (5), 859-869, 2017
872017
A phase I new approaches to neuroblastoma therapy study of buthionine sulfoximine and melphalan with autologous stem cells for recurrent/refractory high‐risk neuroblastoma
JG Villablanca, SL Volchenboum, H Cho, MH Kang, SL Cohn, ...
Pediatric blood & cancer 63 (8), 1349-1356, 2016
862016
Gene expression profiling of E wing sarcoma tumours reveals the prognostic importance of tumour–stromal interactions: a report from the C hildren's O ncology G roup
SL Volchenboum, J Andrade, L Huang, DA Barkauskas, M Krailo, ...
The Journal of Pathology: Clinical Research 1 (2), 83-94, 2015
842015
Neuroblastoma survivors are at increased risk for second malignancies: a report from the International Neuroblastoma Risk Group Project
MA Applebaum, Z Vaksman, SM Lee, EA Hungate, TO Henderson, ...
European Journal of Cancer 72, 177-185, 2017
832017
Characterization of molecular defects in isovaleryl-CoA dehydrogenase in patients with isovaleric acidemia
AWA Mohsen, BD Anderson, SL Volchenboum, KP Battaile, K Tiffany, ...
Biochemistry 37 (28), 10325-10335, 1998
821998
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database
DA Morgenstern, WB London, D Stephens, SL Volchenboum, T Simon, ...
European Journal of Cancer 65, 1-10, 2016
752016
Bioinformatic analysis and post-translational modification crosstalk prediction of lysine acetylation
Z Lu, Z Cheng, Y Zhao, SL Volchenboum
PloS one 6 (12), e28228, 2011
702011
Second malignancies in patients with neuroblastoma: The effects of risk‐based therapy
MA Applebaum, TO Henderson, SM Lee, N Pinto, SL Volchenboum, ...
Pediatric blood & cancer 62 (1), 128-133, 2015
692015
Second malignancies in patients with neuroblastoma: The effects of risk‐based therapy
MA Applebaum, TO Henderson, SM Lee, N Pinto, SL Volchenboum, ...
Pediatric blood & cancer 62 (1), 128-133, 2015
692015
Use of wearable, mobile, and sensor technology in cancer clinical trials
SM Cox, A Lane, SL Volchenboum
JCO clinical cancer informatics 2, 1-11, 2018
662018
Comprehensive Pediatric Hospital Medicine
LB Zaoutis, VW Chang
622007
Age, diagnostic category, tumor grade, and mitosis-karyorrhexis index are independently prognostic in neuroblastoma: an INRG project
E Sokol, AV Desai, MA Applebaum, D Valteau-Couanet, JR Park, ...
Journal of Clinical Oncology 38 (17), 1906, 2020
602020
CAPriCORN: Chicago area patient-centered outcomes research network
AN Kho, DM Hynes, S Goel, AE Solomonides, R Price, B Hota, SA Sims, ...
Journal of the American Medical Informatics Association 21 (4), 607-611, 2014
602014
Synergistic myeloma cell death via novel intracellular activation of caspase-10–dependent apoptosis by carfilzomib and selinexor
S Rosebeck, MM Alonge, M Kandarpa, A Mayampurath, SL Volchenboum, ...
Molecular cancer therapeutics 15 (1), 60-71, 2016
492016
Tailoring therapy for children with neuroblastoma on the basis of risk group classification: past, present, and future
WH Liang, SM Federico, WB London, A Naranjo, MS Irwin, ...
JCO Clinical Cancer Informatics 4, 895-905, 2020
472020
The system can't perform the operation now. Try again later.
Articles 1–20